#Vitaminb3

A large wave of new evidence is adding to the chorus of dermatologists recommending nicotinamide, a form of vitamin B3, as a daily supplement to help prevent new skin cancers in people at high risk. In a growing body of research, this common dietary ingredient—already familiar to many as a multivitamin staple—appears to reduce the number of new skin cancer cases when taken regularly over time. The findings come amid a broader push in public health to combine everyday wellness habits with proven medical prevention strategies, a message that resonates deeply in sun-soaked Thailand where outdoor work and cultural gatherings intensify UV exposure.

A new analysis of nearly 34,000 U.S. veterans suggests that taking nicotinamide, a widely available form of Vitamin B3, is linked to a meaningful reduction in non-melanoma skin cancers among people who have already had skin cancer. The biggest benefit was seen in those who started the supplement after their first cancer diagnosis. Participants who took 500 mg of nicotinamide twice daily for at least one month experienced about a 14% overall reduction in future skin cancers, with a striking 54% risk drop among those who began after their initial cancer. The cancers most affected were basal cell carcinoma and squamous cell carcinoma, the two most common non-melanoma forms. Importantly, the study did not assess melanoma.

A new study from researchers at the University of California, Irvine, examines how a combination of vitamin B3 and green tea extract can momentarily restore youthful energy balance in aging mouse brain cells in a controlled lab setting. Published in GeroScience, the research suggests that certain cellular aging processes may be reversible, hinting at future strategies to address dementia risk in Thailand’s rapidly graying society. Yet scientists caution that the findings are confined to dish-based experiments and have not been tested in living animals or humans. Significant challenges remain in determining safe dosages, delivery methods, and overall applicability.

Groundbreaking laboratory research from the University of California Irvine demonstrates that combining vitamin B3 with green tea extract can restore youthful energy balance in aging mouse brain cells within 16-24 hours, potentially clearing Alzheimer’s-associated protein deposits and revitalizing cellular cleanup systems. The study, published in GeroScience, reveals that specific aspects of neuronal aging may be surprisingly reversible at the cellular level, offering hope for Thailand’s rapidly expanding elderly population facing escalating dementia risks. However, leading researchers emphasize critical limitations: these remarkable effects occurred only in laboratory dish conditions, have not been tested in living animals or humans, and face significant challenges in dosage, delivery, and safety that must be resolved before any therapeutic applications emerge.

A lab study from the University of California, Irvine reports that a simple combination of nicotinamide (a form of vitamin B3) and EGCG, the antioxidant in green tea, restored “youthful” energy balance in aging mouse neurons and helped clear Alzheimer’s‑linked protein clumps within 16–24 hours. The work, published in the journal GeroScience, suggests that some aspects of brain cell aging may be surprisingly reversible — at least in a dish — but experts caution that the findings have not yet been tested in living animals or people, and that dosing, delivery and safety remain open questions (GeroScience, Springer; PubMed; UC Irvine news; StudyFinds summary).

Scientists at the University of California, Irvine have achieved a remarkable breakthrough that could revolutionize brain health for Thailand’s rapidly aging population, demonstrating that two everyday nutritional compounds can literally reverse cellular aging in damaged brain tissue within mere hours of treatment. The extraordinary research, published in the prestigious journal GeroScience, reveals how vitamin B3 combined with green tea extract can restore youthful energy production and waste-clearing mechanisms to severely deteriorated neurons, offering transformative hope for the estimated 600,000 Thai families currently struggling with dementia-related challenges. This discovery carries profound implications for Thailand’s healthcare future, where dementia cases are expected to reach nearly two million by 2030 as the kingdom experiences one of the world’s fastest population aging rates, creating urgent demand for accessible, scientifically-proven intervention strategies that can be implemented before cognitive decline becomes irreversible.

A groundbreaking study from the University of California, Irvine suggests that aging brain cells can regain youthful energy within hours using compounds common in Thai homes. In lab tests on aging mouse neurons, a precise mix of nicotinamide (active vitamin B3) and epigallocatechin gallate (EGCG) from green tea restored energy production to levels seen in healthy young neurons within 16 hours. The findings, published in GeroScience, offer hope for Thailand’s growing elderly population while reinforcing the value of traditional Thai foods and beverages in cognitive health.

A pioneering study from the University of California, Irvine, has revealed that a combination of vitamin B3 (nicotinamide) and the key green tea antioxidant EGCG could quickly restore youthful function to aging brain cells — at least in a laboratory setting — sparking hope for future therapies addressing cognitive decline and Alzheimer’s disease. The findings, published in the journal GeroScience, have captured international attention, including in Thailand, where dementia prevalence continues to rise and natural preventive approaches are increasingly sought after (studyfinds.org).

A new study spotlights nicotinamide riboside (NR), a form of vitamin B3, as a promising option to support brain health and slow Alzheimer’s progression. Researchers from the University of Delaware College of Health Sciences and the National Institute on Aging found that NR can cross the blood-brain barrier and may help preserve neurons and brain energy metabolism as people age.

Alzheimer’s disease remains a major health challenge worldwide, including Thailand, where an aging population increases demand for prevention and treatment strategies. Current therapies primarily address symptoms rather than the disease itself. The latest findings align with a broader interest in NAD+ precursors like NR as potential neuroprotective options because they help maintain cellular energy in the brain. Data from leading research institutions suggests NR could offer protective benefits against neurodegeneration.